Anticonvulsive effect of dapsone. interaction with phenytoin in the kainic acid model of seizures

Proceedings of the Western Pharmacology Society

Volumn 40, Issue , 1997, Pages 95-96

  Garcia Aren, G ^a   Flores Murrieta, F J ^b   Rios, C ^a  

^a Section de Terapéutica Experimental   (United States)

^b Institute National de Neurologia y Neurocirugia   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DAPSONE; KAINIC ACID; PHENYTOIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; IMMUNOMODULATION; KAPOSI SARCOMA; LEPROSY; SEIZURE;

ADMINISTRATION, ORAL; ANIMALS; ANTICONVULSANTS; DAPSONE; DRUG INTERACTIONS; INJECTIONS, INTRAVENOUS; KAINIC ACID; PHENYTOIN; RATS; SEIZURES;

EID: 0030724656     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Gordon R, Peters J, Ghoul DC, Murray JF, Levy L & Biggs JT. Proc Soc Exp Biol Med 150. 485 (1975).
2. Colleman M, Breckenridge D & Park B. J Clin Pharmacol 28.389 (1989).
3. Snyman JR, Jacyk WK, Lizamore DJ & Sommers DK. Clin Drug Invest 10.179 (l995).
4. Poulsen A, Hultberg B, Thomsen K & Wantzin GL. Lancet 1.560 (1984).
5. Altagracia M, Monroy-Noyola A, Osorio-Rico L, Kravsov J, Alvarado-Carrillo R, Manjarrez-Marmolejo J & Rios C. Neurosci Lett 176.52(1994).
6. Morris JC, Dodson E, Hatlelid JM & Ferrendelli JA. Neurology 37.111 (1987).
7. Kroboth PD. Design and Analysis of Drug Interaction Studies, (eds) RB Smith, PD Kroboth & RP Juhl, Cincinnati, 1986, p.15.
8. Nadler JV. Life Sei 29.165 (1981).
9. Fromm GH, Chattha AS, Terrence CF & Glass JD. Eur J Pharmacol 78.403 (1982).